Article info
Basic and translational research
Extended report
Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
- Correspondence to Dr Jörg H W Distler, Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany; joerg.distler{at}uk-erlangen.de
Citation
Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis
Publication history
- Received April 14, 2014
- Revised August 4, 2014
- Accepted August 10, 2014
- First published September 1, 2014.
Online issue publication
December 11, 2015
Article Versions
- Previous version (1 September 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/